SPDR S&P Biotech ETF $XBI Shares Sold by NewEdge Advisors LLC

NewEdge Advisors LLC cut its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 29.4% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 14,764 shares of the exchange traded fund’s stock after selling 6,155 shares during the quarter. NewEdge Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $1,886,000 as of its most recent SEC filing.

Other institutional investors also recently made changes to their positions in the company. Wealth Management Partners LLC acquired a new position in shares of SPDR S&P Biotech ETF during the first quarter valued at $547,000. Apella Capital LLC acquired a new stake in shares of SPDR S&P Biotech ETF in the 4th quarter worth about $490,000. Mirae Asset Global Investments Co. Ltd. increased its holdings in shares of SPDR S&P Biotech ETF by 106.9% in the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 26,570 shares of the exchange traded fund’s stock worth $3,240,000 after acquiring an additional 13,729 shares during the period. Keystone Investors PTE Ltd. bought a new stake in SPDR S&P Biotech ETF in the 4th quarter valued at about $12,022,000. Finally, Greystone Financial Group LLC bought a new stake in SPDR S&P Biotech ETF in the 4th quarter valued at about $658,000.

SPDR S&P Biotech ETF Stock Down 2.9%

SPDR S&P Biotech ETF stock opened at $147.01 on Friday. The firm has a 50-day moving average price of $146.16 and a two-hundred day moving average price of $134.34. The firm has a market capitalization of $9.70 billion, a price-to-earnings ratio of 11.47 and a beta of 0.82. SPDR S&P Biotech ETF has a 52-week low of $84.39 and a 52-week high of $165.71.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.